-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-FDA Qualifies Total Hip Bone Mineral Density As Surrogate Endpoint For Osteoporosis Drug Development

路透·12/19/2025 20:22:06

登錄查看新聞詳情